Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Leaks After LAAO Do Matter, Experts Agree

Todd Neale

June 10, 2024

Presentation NY Valves 2024

TMVR Will Rely on the Evolution of Imaging: Current Trends and Future Possibilities

Presenter: Augustin Coisne

June 07, 2024

Presentation NY Valves 2024

Interventional Imaging: The Evolution Procedural Imaging Tools

Presenter: Rebecca T. Hahn

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation NY Valves 2024

Where Do We Go Next?

Presenter: Roxana Mehran

June 06, 2024

Presentation NY Valves 2024

What Data and Valve Design Means for Valve Selection in Women

Presenter: Ruby Satpathy

June 06, 2024

Presentation NY Valves 2024

FX+: The Next Step in Addressing Lifetime Management

Presenter: Laura Flannery

June 06, 2024

Presentation NY Valves 2024

An Evidence Based Discussion: SMART and Evolut in Women

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

Not All Valves Are Designed Alike

Presenter: Matthew W. Sherwood

June 06, 2024

Presentation NY Valves 2024

Redo TAVR Through Embolized Evolut FX Valve

Presenter: Richard Tanner

June 06, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Advertisement

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

National Data Point to Soaring TAVI Rates in Patients Under 65

Leaks After LAAO Do Matter, Experts Agree

TMVR Will Rely on the Evolution of Imaging: Current Trends and Future Possibilities

Interventional Imaging: The Evolution Procedural Imaging Tools

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Where Do We Go Next?

What Data and Valve Design Means for Valve Selection in Women

FX+: The Next Step in Addressing Lifetime Management

An Evidence Based Discussion: SMART and Evolut in Women

Not All Valves Are Designed Alike

Redo TAVR Through Embolized Evolut FX Valve

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content